Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

The importance of hereditary genetic testing for young patients with cancer

The importance of hereditary genetic testing for young patients with cancer

65% of all cancers occur at age 65 or older, which is why cancer is generally known as a "disease of old age." However, cancer incidence is increasing in young adults, and we know that cancers that develop at younger ages have different genetic characteristics. In the United States alone, 70 thousand adolescents and young adults (aged 15 - 39) are diagnosed with cancer each year. Scientific data suggest that some cancers seen in adolescent and young adult patients may have distinctive genetic and biological characteristics.

Key findings

  • 21% of patients with early-onset cancer and 13% of young adult patients with cancer had an inherited / germline / parent-transmitted genetic mutation.
  • Among patients with early-onset cancer, inherited mutations were most often seen in pancreatic, breast or kidney cancers. The most common genetic mutations involved the BRCA1, BRCA2, ATM and CHEK2 genes and mutations most often found in Lynch syndrome.
  • Among young adult patients with cancer, germline TP53 mutations were more common, which was consistent with Li-Fraumeni syndrome.
  • The higher frequency of germline mutations among patients with early-onset cancer supports genetic testing regardless of tumor type.

- Related topic: Familial, Hereditary and Sporadic: Concepts often confused in cancer

Details of the study

American Association for Cancer Research Study number 1122, presented at its 2nd Virtual Annual Meeting, investigated the frequency of cancer-associated germline/hereditary mutations in patients with cancer between the ages of 18 and 39. The researchers performed germline mutation analysis in 1,201 patients aged 18-39 with various solid/organ tumors. Their analysis used the MSK-IMPACT germline genetic testing protocol, which used 88 genes previously associated with cancer predisposition in a next-generation sequencing panel. The researchers divided patients into two categories: early-onset cancer (877 patients) and young adult cancer (324 patients). Early-onset cancer was defined as cancer in which the median age at diagnosis for the cancer type was > 1 standard deviation above age 39, and young adult cancer was defined as cancer in which the median age at diagnosis was below < 1 standard deviation; in other words, early-onset cancer referred more to middle ages, while young adult cancer referred to younger ages. The researchers found that the cancers most frequently diagnosed among patients with early-onset cancer were colorectal (large bowel), breast, kidney, pancreatic and ovarian cancers. Among those with young adult cancer, the most frequent diagnoses were sarcoma as well as brain, testicular and thyroid cancers. The frequency of likely pathogenic or pathogenic germline genetic alterations was 21% in the early-onset cancer group and 13% in the young adult cancer group. Among patients with early-onset cancer, the most commonly mutated genes were BRCA2, BRCA1, CHEK2 and ATM, and pancreatic, breast and kidney cancers had the highest rates of germline pathogenic genetic alterations. By contrast, TP53 and SDHA mutations were most common in the young adult cancer group. The 18.1% mutation frequency in young adult patients with sarcoma was similar to the frequency in the early-onset group.

Conclusion & Commentary

It is surprising that these inherited mutations are significantly more frequent in young patients with cancer than we previously thought. This study shows that the prevalence of hereditary cancer syndromes in young adults with cancer is not uniform. We found that germline/hereditary mutations were very common in young patients with cancer types that typically occur at older ages and that we categorize as early-onset cancers; 21% of these patients carry a germline genetic alteration. On the other hand, the frequency of germline mutations was lower, at 13%, in the remaining young adult patients… These results suggest that the increased frequency of germline mutations in patients with early-onset cancer supports a role for genetic testing regardless of tumor type.

Sources

By Jo Cavallo.
Young Adults With Cancer May Benefit From Germline Genetic Testing
ascopost.com - 26 June 2020

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

The importance of hereditary genetic testing for young patients with cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy